Skip to main content

Table 2 Dyslipidemia rate and the characteristics

From: Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study

  Normolipidemia Dyslipidemia P value
Non-treatment Treatment
N (%) 152 (12.3%) 345 (28.1%) 734 (59.6%) < 0.0001
Sex
male 92 (11.0%) 246 (29.4%) 500 (59.7%)  
female 60 (15.3%) 99 (25.2%) 234 (59.5%) 0.0600
Age (years)
< 50 46 (12.5%) 189 (51.4%) 133 (36.1%)  
50–60 57 (14.7%) 90 (23.3%) 240 (62.0%)  
> 60 49 (10.3%) 66 (13.9%) 361 (75.8%) < 0.0001
HbA1c (%)
< 7 49 (14.5%) 82 (24.3%) 207 (61.2%)  
7–10 53 (9.2%) 153 (26.5%) 372 (64.4%)  
> 10 50 (15.9%) 110 (34.9%) 155 (49.2%) < 0.0001
T2DM duration (years)
< 3 33 (11.7%) 125 (44.5%) 123 (43.8%)  
3–10 67 (13.8%) 151 (31.1%) 267 (55.1%)  
> 10 52 (11.2%) 69 (14.8%) 344 (74.0%) < 0.0001
BMI (kg/m2)
< 24 75 (20.5%) 74 (20.3%) 216 (59.2%)  
≥ 24 77 (8.9%) 271 (31.3%) 518 (59.8%) < 0.0001
Hypertension
Yes 62 (10.7%) 108 (18.7%) 409 (70.6%)  
No 90 (13.8%) 237 (36.3%) 325 (49.8%) < 0.0001
FLD
Yes 20 (6.5%) 97 (31.7%) 189 (61.8%)  
No 132 (14.3%) 248 (26.8%) 545 (58.9%) 0.0010
  1. Values were frequency (percentage). P value was calculated by Chi-square test or Fisher’s exact test